New diabetes clinical trial: Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus
Published on: April 16, 2019 at 07:00PM Condition: Type 1 Diabetes Interventions: Drug: SAR341402; Drug: Insulin Aspart Sponsor: Sanofi Completed
No comments:
Post a Comment